Skip to content

Assessment of the routine application of double modified nasopharyngeal airways versus the use of low-flow nasal cannula during pediatric upper gastrointestinal endoscopy.

Application of double modified nasopharyngeal airways during pediatric upper gastrointestinal endoscopy.

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
PACTR
Registry ID
PACTR202205629173217
Enrollment
50
Registered
2022-05-31
Start date
2022-06-01
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Respiratory Anaesthesia

Interventions

Group A
Group B

Sponsors

Mostafa Mansour Hussein
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: The study will enroll children of both sexes aged between 1 and 10 years old with an ASA physical status of I-II who will undergoing elective upper GI endoscopy under deep sedation.

Exclusion criteria

Exclusion criteria: Children will be excluded from the study if they have significant cardiovascular, hepatic, renal, or respiratory disorders. Patients with upper airway anatomical disorders, malignancy, known allergies to the drugs used, or who will require emergency procedures will be also excluded from the study.

Design outcomes

Primary

MeasureTime frame
The frequency of hypoxic events (SaO2 <90% for more than 15 seconds as identified by pulse oximetry or apnea for more than 15 seconds as identified by respiratory monitoring).

Secondary

MeasureTime frame
Duration of endoscopy, gastroenterologist's satisfaction, incidence of nasopharyngeal injury caused by NPA insertion, bradycardia (heart rate <60 beats/min), hypotension (systolic blood pressure <20% from baseline), indication of endoscopy, and the occurrence of other side effects (e.g., nausea and vomiting).

Countries

Egypt

Contacts

Public ContactMostafa Mansour Hussein

Assistant professor of anesthesia and intensive care faculty of medicine Ain Shams university

mostafa.mansor@med.asu.edu.eg00201093322145

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Aug 9, 2026